Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M405136200 on August 31, 2004

J. Biol. Chem., Vol. 279, Issue 45, 46715-46722, November 5, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/45/46715    most recent
M405136200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, S.
Right arrow Articles by Martegani, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, S.
Right arrow Articles by Martegani, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Activation State of the Ras2 Protein and Glucose-induced Signaling in Saccharomyces cerevisiae*

Sonia Colombo{ddagger}, Daniela Ronchetti{ddagger}, Johan M. Thevelein§, Joris Winderickx¶, and Enzo Martegani{ddagger}||

From the {ddagger}Dipartimento di Biotecnologie e Bioscienze, Università Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy, §Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, Katholieke Universiteit Leuven and Department of Molecular Microbiology, Flemish Interuniversity Institute of Biotechnology (VIB), Kasteelpark Arenberg 31, B-3001 Leuven-Heverlee, Flanders, Belgium, and Laboratorium voor Functionele Biologie, Katholieke Universiteit Leuven, Instituut voor Plantkunde en Microbiologie, Kasteelpark Arenberg 31, B-3001 Leuven-Heverlee, Flanders, Belgium

Received for publication, May 10, 2004 , and in revised form, August 24, 2004.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The activity of adenylate cyclase in the yeast Saccharomyces cerevisiae is controlled by two G-protein systems, the Ras proteins and the G{alpha} protein Gpa2. Glucose activation of cAMP synthesis is thought to be mediated by Gpa2 and its G-protein-coupled receptor Gpr1. Using a sensitive GTP-loading assay for Ras2 we demonstrate that glucose addition also triggers a fast increase in the GTP loading state of Ras2 concomitant with the glucose-induced increase in cAMP. This increase is severely delayed in a strain lacking Cdc25, the guanine nucleotide exchange factor for Ras proteins. Deletion of the Ras-GAPs IRA2 (alone or with IRA1) or the presence of RAS2Val19 allele causes constitutively high Ras GTP loading that no longer increases upon glucose addition. The glucose-induced increase in Ras2 GTP-loading is not dependent on Gpr1 or Gpa2. Deletion of these proteins causes higher GTP loading indicating that the two G-protein systems might directly or indirectly interact. Because deletion of GPR1 or GPA2 reduces the glucose-induced cAMP increase the observed enhancement of Ras2 GTP loading is not sufficient for full stimulation of cAMP synthesis. Glucose phosphorylation by glucokinase or the hexokinases is required for glucose-induced Ras2 GTP loading. These results indicate that glucose phosphorylation might sustain activation of cAMP synthesis by enhancing Ras2 GTP loading likely through inhibition of the Ira proteins. Strains with reduced feedback inhibition on cAMP synthesis also display elevated basal and induced Ras2 GTP loading consistent with the Ras2 protein acting as a target of the feedback-inhibition mechanism.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In Saccharomyces cerevisiae the addition of glucose or other rapidly fermentable sugars to derepressed cells (carbon-starved or growing on a non-fermentable carbon source) triggers a remarkable variety of regulatory phenomena, including many rapid changes at the post-translational and transcriptional level. Several signaling pathways are activated by glucose. One of the best studied pathways is the cAMP/PKA1 pathway. The main component of this signaling transduction pathway is adenylate cyclase, which catalyzes the synthesis of cAMP. In S. cerevisiae adenylate cyclase activity is controlled by the Ras proteins. These proteins are members of the small GTPase superfamily, which are active in the GTP-bound form and inactive in the GDP-bound form. Recently it has been demonstrated that in S. cerevisiae adenylate cyclase activity is also controlled by a heterotrimeric G{alpha}-protein, Gpa2 (1). A G-protein-coupled receptor, Gpr1, has been identified to be responsible for activation of the Gpa2 protein (2–4). Two triggers are known to activate the cAMP/PKA pathway: the addition of glucose to derepressed cells and intracellular acidification. The Gpr1/Gpa2 G-protein-coupled receptor system is only required for glucose activation of cAMP synthesis (2, 5). The results reported in the literature about the role played by the Ras proteins in activation of cAMP synthesis are in part contradictory. Colombo et al. (5) showed that intracellular acidification (but not glucose) caused an increase in the GTP/GDP ratio on the Ras proteins, suggesting that only intracellular acidification would stimulate cAMP synthesis through activation of the Ras proteins. Other data reported by Rudoni et al. (6) using another assay show that the addition of glucose to glucose-starved cells also causes a fast increase of the Ras2-GTP level. Two different assays have been used to analyze quantitatively the guanine nucleotides bound to the Ras proteins in vivo. The first assay was developed by Gibbs et al. (7) and used by Colombo et al. (5). After labeling the cells in vivo with [32P]orthophosphate, the Ras proteins were immunoprecipitated with antibodies against the human Ras protein (v-H-ras 259). Guanine nucleotides were extracted, separated by TLC, and quantitated by phosphorimager technology. With this assay, the GTP/GDP ratio on the yeast Ras proteins could be measured only after overexpression of Ras2 protein indicating that the sensitivity of this assay is probably not very high. A more recent assay to analyze quantitatively the guanine nucleotides bound to the Ras proteins in vivo was described by Taylor and Shalloway (8) and exploits the known specificity of the interaction between Ras-GTP and the Ras-binding domain (RBD) of Raf-1 to detect activated Ras. Because there is a high degree of homology between yeast and mammalian Ras proteins, the yeast Ras proteins are able to interact with the RBD of Raf-1. As a result the assay could be used successfully by Rudoni et al. (6) to measure the GTP loading on yeast Ras2 without overexpression of this protein. In this work we have used the highly sensitive non-radioisotopic pull-down assay for Ras2 GTP loading to study the requirements for the rapid glucose enhancement of GTP loading. We show that it is dependent on Cdc25 and that deletion of the Ira proteins causes constitutively high GTP loading. Remarkably, also deletion of GPR1 or GPA2 enhances basal and induced Ras2 GTP loading. It is known that glucose phosphorylation by glucokinase or the hexokinases is required for glucose-induced cAMP signaling (9, 10). This glucose phosphorylation requirement can also be fulfilled in a glucose transport deficient strain by provision of intracellular maltose (11). We show that glucose-induced Ras2 GTP loading is dependent on precisely the same requirements indicating that glucose phosphorylation probably acts through Ras to sustain cAMP signaling. Finally we provide evidence that the Ras proteins might be a target for the stringent feedback inhibition of PKA on cAMP synthesis.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Strains and Growth Conditions—The yeast strains used in this study are indicated in Table I. Cells were grown in 1% (w/v) yeast extract, 2% (w/v) Bacto-peptone (YP) supplemented with either 3% (w/v) glycerol, 0.1% (w/v) glucose and 50 mg/liter adenine, or 2% (w/v) glucose and 50 mg/liter adenine (YPDA). Strains carrying a plasmid were grown in minimal media that contained 0.67% (w/v) yeast nitrogen base without amino acids, 3% (w/v) glycerol, 0.1% (w/v) glucose, and the required supplements (50 mg/liter).


View this table:
[in this window]
[in a new window]
  		TABLE I
List of yeast strains

 
Strain KP-JW21b (hxk1::HIS3 hxk2::LEU2 glk1::LEU2 ira2::URA3) was obtained by Katrien Pardons (Katholieke Universiteit Leuven) via crossing of strain YSH757 (hxk1::HIS3 hxk2::LEU2 glk1::LEU2) with strain PM903 (ira1::URA3 ira2::URA3). Deletions in HXK1, HXK2, GLK1, and IRA2 genes were checked by PCR. Strains W303–1A (YCpRAS2) and W303–1A (YCpRAS2Val19) were obtained by transforming strain W303–1A with plasmids YCpRAS2 and YCpRAS2Val19 (12).

Determination of the Ras2-GTP/Total Ras2 Ratio in Vivo—Determination of the ratio Ras2-GTP/total Ras2 was performed essentially as described by Taylor and Shalloway (8) with some modification (6). This assay exploits the known specificity of the interaction between Ras-GTP and the RBD of Raf-1 to detect activated Ras. Cells were collected by centrifugation and resuspended in 25 mM MES buffer, pH 6, (108 cells/ml) for about 20 min. At time 0 glucose or DNP was added, and samples were collected by filtration on nitrocellulose filters. After the addition of ice-cold lysis buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 1% (w/v) Nonidet P-40, 0.25% (w/v) sodium deoxycholate, 10% (w/v) glycerol, 25 mM NaF, 10 mM MgCl2, 1 mM EDTA, 1 mM sodium vanadate, one tablet of Protease Inhibitor Mixture from Roche Applied Science in 50 ml of extraction medium), cells were disrupted with glass beads in a Fastprep instrument. Cleared supernatant (containing 200 µg of total protein) was incubated with 20 µl of bed volume of glutathione S-transferase (GST)-RBD fusion protein pre-bound to glutathione-Sepharose for 1 h at 4 °C. The GST·RBD fusion protein was prepared using the expression vector pGEX2T-RBD, which encodes amino acids 1–149 of Raf-1 fused to GST. This plasmid was kindly provided by A. Wittinghofer (Max-Planck Institute, Dortmund, Germany). The expression of GST·RBD fusion protein in Escherichia coli was induced with 0.1 mM isopropyl 1-thio-{beta}-D-galactopyranoside for 4–5 h at 30 °C, and the fusion protein was purified on glutathione-Sepharose beads. The beads were washed with phosphate-buffered saline containing 1 mM EDTA and subsequently with complex phosphate-buffered saline buffer (phosphate-buffered saline 1x, 1% (w/v) Triton X-100, 10% (w/v) glycerol, 1 mM EDTA, 0.5 mM dithiothreitol, 1 mM sodium vanadate, one tablet of Protease Inhibitor Mixture from Roche Applied Science in 50 ml of this solution). Bound proteins were eluted with 2x SDS-sample buffer (100 mM Tris-HCl, pH 6.8, 2% w/v {beta}-mercaptoethanol, 4% (w/v) SDS, 0.2% (w/v) bromphenol blue, 20% (w/v) glycerol), separated by SDS-PAGE, blotted onto nitrocellulose, immunodecorated with anti-Ras2 polyclonal antibodies (SC-6759, Santa Cruz Biotechnology), and revealed with an ECL Western blotting analysis system (Amersham Biosciences). Total Ras2 protein was detected in cleared lysate by Western blotting using the same anti-Ras2 antibodies. The ratios of Ras2-GTP/total Ras2 were determined by densitometric analysis (Scion-Image software).

All experiments were done in triplicate, and error bars are reported in the figures. In our experimental conditions anti-Ras2 antibodies recognize in a specific way yeast Ras2 protein as shown in Fig. 1A because no signal was detected in strains bearing a RAS2 deletion.



View larger version (24K):
[in this window]
[in a new window]
  		FIG. 1.
Specificity of Ras2-GTP detection system. A, immunoblots of Ras2 in cell lysate (2 µg of total protein) of the following strains: W303–1A grown in minimal medium (lane 1), W303–1A (YCpRAS2) (lane 2), ras2{Delta} (lane 3), ras1{Delta} ras2{Delta} bcy1 (lane 4), and W303–1A grown in YPDA (lane 5). B, purified Ras2 protein was bound either to GTP or GDP and incubated with GST·RBD fusion protein prebound to glutathione-Sepharose. Total Ras2-GTP (lane 1), total Ras2-GDP (lane 1), and bound proteins (lane 2) eluted with SDS-PAGE sample buffer were loaded on an SDS-PAGE. Ras2 proteins were detected by immunoblotting with anti-Ras2 polyclonal antibodies. Only the activated form of Ras2 was able to bind to the resin.

 
For evaluation of the reliability of the assay we set up conditions to load purified Ras2 protein specifically either with GTP or with GDP. For this purpose 1 µg of purified Ras2 protein (13) was incubated at room temperature for 30 min in 150 µl of phosphate-buffered saline 1x (containing one tablet of Protease Inhibitor Mixture in 50 ml of buffer) in the presence of 5 mM EDTA and either 1 mM GTP or 1 mM GDP. The removal of Mg2+ by EDTA partially unfolds the protein and induces an open conformation enhancing the binding of either GTP or GDP. Immediately after incubation, an excess amount of MgCl2 (20 mM) was added to refold the Ras2 protein so that the nucleotide was locked in the protein. Both these fractions were incubated with GST·RBD fusion protein pre-bound to glutathione-Sepharose for 1 h at 4 °C. Bound proteins were eluted with 2x SDS-sample buffer, separated by SDS-PAGE, blotted onto nitrocellulose, immunodecorated with anti-Ras2 polyclonal antibodies (SC-6759, Santa Cruz Biotechnology), and revealed with the ECL Western blotting analysis system (Amersham Biosciences). Total Ras2 protein (bound either to GTP or to GDP) was detected by Western blotting using the same anti-Ras2 antibodies. Only the activated form of Ras2 was able to bind to the resin (Fig. 1B) indicating that the assay is specific for Ras2-GTP.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Overexpression of Ras2 Abolishes Glucose-induced GTP Loading on Ras2—We previously reported an increase in the GTP-loading state of Ras after intracellular acidification with the protonophore 2,4 dinitrophenol using a method based on in vivo labeling of strains overexpressing Ras2. This method, however, did not revealed a glucose-induced increase in Ras GTP loading (5). More recently, we adopted the more sensitive Ras-GTP/Raf interaction assay, and this allowed us to demonstrate a rapid activation of Ras2 upon the addition of glucose to glucose-starved cells (6). We now show, using the more sensitive assay, that the overexpression of Ras2 abolished the glucose-induced increase in Ras2-GTP and delays the increase triggered by intracellular acidification (Fig. 2B), whereas a fast increase was obtained in a wild-type W303–1A strain after the addition of glucose (Fig. 2, A, C, and D) or 2,4 dinitrophenol (Fig. 2A). This provides an explanation for the discrepancy between the results of our two previous studies and confirms the results reported by Rudoni et al. (6) performed with a different wild type strain. The inset of Fig. 2B shows a Western blot giving a rough evaluation of the Ras2 overexpression in W303 (YepRAS2); from this data a 15-fold increase was calculated in comparison with the wild type W303–1A.



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 2.
Effect of Ras2 overexpression on Ras2-GTP loading induced by glucose or by acidification. Amount of Ras2-GTP after addition of 2 mM 2,4-dinitrophenol ({square}) or 100 mM glucose ({diamondsuit}) to W303–1A (A) and W303–1A (YEpRAS2) (B). Cells were collected by centrifugation and resuspended in MES buffer (108 cells/ml) for 20 min. At time 0 glucose or 2,4-dinitrophenol was added, and samples were collected by filtration. Lysates were subjected to affinity purification with GST-RBD prebound to glutathione-Sepharose. Ras2 proteins were detected by immunoblotting with anti-Ras2 polyclonal antibodies. The ratio of Ras2-GTP/total Ras2 was determined by densitometric analysis. Inset: immunoblots of Ras2 in cell lysate (1.5 µg of total protein) (total Ras2 level) of W303–1A (lane 1) and W303–1A (YEpRAS2) (lane 2) and Ras2 bound to GST-RBD eluted with SDS-PAGE sample buffer (level of Ras2-GTP). C, immunoblots of Ras2 in cell lysate (2.6 µg of total protein) (total Ras2 level) of W303–1A, and (D) Ras2 bound to GST-RBD eluted with SDS-PAGE sample buffer (level of Ras2-GTP) at different times after the addition of glucose.

 
Addition of Glucose Enhances the Ras2-GTP Level and the Rapid Increase Is Dependent on Cdc25—Because the addition of glucose triggered a rapid increase in the Ras2-GTP level we have evaluated whether this increase was dependent on Cdc25, the main GDP/GTP exchange factor for Ras in yeast. The addition of 100 mM glucose to derepressed cells of a strain deleted for CDC25 and rescued by overexpression of TPK1 did not show the rapid increase in the Ras2-GTP/total Ras2 ratio (Fig. 3). The Ras2 GTP loading state increased slowly to a level similar to that of the wild type strain. Hence, Cdc25 is required for the rapid increase. It is also evident that TPK1 overexpression has a negative effect on Ras2 GTP loading. This could be due to a feedback caused by high PKA activity and suggests (as reported later) that Ras2 is a possible target of the feedback inhibition.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 3.
Fast glucose-induced Ras2-GTP loading requires Cdc25. GTP content of Ras2 after the addition of 100 mM glucose to cells of the wild type W303–1A ({blacksquare}), W303–1A (YEpTPK1) ({circ}) and cdc25{Delta} (YEpTPK1)({diamondsuit}) strains. Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 
Ira1 and Ira2 Negatively Regulate the Ras2 Protein Activation State and Are Required for the Glucose-induced Increase in Ras2 GTP Loading—Tanaka et al. (14) reported that in ira mutants the Ras2 proteins accumulate in the GTP-bound form, whereas in the wild type strain these proteins were found mostly in the GDP-bound form, indicating that Ira1 and Ira2 negatively regulate the level of Ras-GTP. Our results with the new assay confirm these conclusions. In a strain containing only the wild type IRA2 gene (ira1{Delta}) the initial Ras2-GTP/total Ras2 ratio was about 3 times higher compared with wild type cells. However, the ratio still increased after the addition of glucose (Fig. 4A). In a strain containing only the IRA1 gene (ira2{Delta}) the initial ratio was about 6 times higher than in the wild type strain indicating that Ira2 plays a prominent role in controlling the basal Ras2 GTP loading state. In addition, this strain did not show any further glucose-induced increase in Ras2 GTP loading (Fig. 4A). A similar result was obtained for the ira1{Delta} ira2{Delta} strain indicating that the Ira proteins (and mainly Ira2) are essential to obtain a normal glucose-induced increase in Ras2 GTP loading probably because the inhibition or deletion of these GTPases already triggers a maximal GTP loading before the addition of the sugar.



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 4.
Deletion of IRA genes caused high level of Ras2-GTP and a poor glucose response. A, GTP content of Ras2 after the addition of 100 mM glucose to cells of wild type W303–1A ({blacksquare}), W303–1A ira1{Delta} ({blacktriangleup}), W303–1A ira2{Delta} (), and W303–1A ira1{Delta} ira2{Delta} ({square}). B, GTP content of Ras2 after the addition of 100 mM glucose to cells of wild type W303–1A ({blacksquare}), W303–1A (YCpRAS2) ({triangleup}), and W303–1A (YCpRAS2Val19) ({circ}) strains. Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 
To confirm the importance of Ras-GTPase activating capacity and/or guanine nucleotide exchange capacity for the glucose-induced increase in Ras-GTP loading we used a strain expressing the RAS2Val19 dominant allele. This allele has strongly reduced GTPase activity, is insensitive to the Ira proteins, and is also independent of the guanine nucleotide exchange factors Cdc25 and Sdc25. The results obtained were similar to those for the ira1{Delta} ira2{Delta} strain. The basal level of Ras2 GTP loading was high, and there was no further glucose-induced increase (Fig. 4B). This effect was specific for RAS2Val19 because a similar experiment with a strain bearing the normal RAS2 gene in the same centromeric vector (YCpRAS2) gave a response practically identical to a wild type (Fig. 4B); however in this case the level of Ras2 overexpression was about 2-fold as shown also in Fig. 1A, lane 2).

Role of the Gpr1-Gpa2 G-protein-coupled Receptor (GPCR) System in Regulation of the Ras2 Protein Activation State— Because the G-protein-coupled receptor Gpr1 and its G{alpha} protein Gpa2 are required for the stimulation of cAMP synthesis by high glucose levels (2, 3, 5, 11), we have investigated whether they are also required for the glucose-induced increase in Ras2 GTP loading. Both in a gpr1{Delta} and in a gpa2{Delta} strain the glucose-induced increase was still present (Fig. 5A). Remarkably however, the GTP loading state of Ras2 was enhanced in both strains. This indicates that the GPCR system in some way negatively interferes with the activation of Ras2.



View larger version (21K):
[in this window]
[in a new window]
  		FIG. 5.
Effect of GPR1 and GPA2 gene deletions on glucose-induced Ras2-GTP loading. A, GTP content of Ras2 after the addition of 100 mM glucose to cells of wild type W303–1A ({blacksquare}), W303–1A gpa2{Delta} ({blacktriangleup}), and W303–1A gpr1{Delta} ({circ}). B, GTP content of Ras2 after the preaddition of 5 mM glucose followed 3 min and 30 s later by the addition of 100 mM glucose to W303–1A (black bars), W303–1A gpa2{Delta} (gray bars), and W303–1A gpr1{Delta} (white bars). Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 
It has been demonstrated that the glucose-induced increase in cAMP is dependent on two mechanisms: a glucose-phosphorylation dependent mechanism, which is already stimulated by low glucose levels of a few millimolars, and the GPCR-dependent mechanism, which is only triggered by high glucose levels (20–100 mM) (11). To determine the effect of the glucose concentration on Ras2 GTP loading, we have measured the Ras2 activation state during sequential addition of a low (5 mM) glucose concentration followed 3.5 min later by a high (100 mM) glucose concentration. Fig. 5B shows that addition of 5 mM glucose did not trigger a detectable increase in Ras2-GTP in the wild type strain. However, in the gpr1{Delta} and gpa2{Delta} strains an increase was observed (Fig. 5B), consistent with the previous observation that the absence of Gpr1 or Gpa2 facilitates Ras activation. Subsequent addition of 100 mM glucose triggered in all strains a further increase in Ras2 GTP; this increase was again more pronounced in gpr1{Delta} and gpa2{Delta} strains.

Glucose Activation of Ras2 Is Dependent on Active Sugar Kinases—In S. cerevisiae glucose phosphorylation is mediated by three isoenzymes. The hexokinases Hxk1 and Hxk2 phosphorylate glucose as well as fructose (15), whereas the glucokinase Glk1 can only phosphorylate glucose (16). Any one of the three isoenzymes can sustain glucose-induced cAMP signaling, whereas specifically one of the two hexokinases is required for fructose-induced cAMP signaling (9, 10). We have investigated the requirement for glucose phosphorylation using a strain lacking the three sugar kinases (hxk1{Delta} hxk2{Delta} glk1{Delta}) or the two hexokinases (hxk1{Delta} hxk2{Delta}). In the latter strain only the glucokinase Glk1 is active. In the hxk1{Delta} hxk2{Delta} glk1{Delta} strain the glucose-induced increase in Ras2-GTP was absent, whereas in the hxk1{Delta} hxk2{Delta} strain the glucose-induced increase in Ras2-GTP was present but somewhat lower than in the wild type strain (Fig. 6). These results indicate that glucose phosphorylation is required for the glucose-induced increase in Ras2-GTP and that glucokinase alone can sustain the increase. Moreover when we tested the Ras2-GTP increase in a hxk1{Delta}, hxk2{Delta}, glk1{Delta}, ira2{Delta} strain we obtained a result comparable with that observed for ira2{Delta} strain (see Fig. 4A), a high basal level of Ras2-GTP that did not increase after glucose addition. This result suggests that glucose induced Ras2-GTP loading operates likely through an inhibition of the Ira2 protein.



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 6.
Glucose kinases are required for glucose-induced Ras2-GTP loading. GTP content of Ras2 after the addition of 100 mM glucose to cells of wild type W303–1A ({blacksquare}), hxk1{Delta} hxk2{Delta} ({Delta}), hxk1{Delta} hxk2{Delta} glk1{Delta} (), and hxk1{Delta} hxk2{Delta} glk1{Delta} ira2{Delta} ({diamond}) strains. Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 
Glucose-induced Activation of Ras2 in a Glucose Transport-deficient Strain—Recent data have shown that the two essential requirements for glucose-induced activation of cAMP synthesis can be fulfilled separately: the extracellular glucose detection by the GPCR system and the intracellular sugarsensing process requiring the hexose kinases (10, 11). Addition of a low concentration of maltose (0.7 mM), which provides intracellular glucose in the absence of glucose transport, to cells of a strain lacking all physiologically important glucose carriers (HXT1–7, GAL2) did not increase the cAMP level by itself. However, it provided enough glucose phosphorylation to sustain the activation of cAMP synthesis by a high external glucose level through the Gpr1/Gpa2 GPCR system. Fig. 7 shows that in a glucose-transport deficient strain the rapid glucose-induced increase in Ras2-GTP was largely absent. This is in agreement with the requirement for active glucose phosphorylation because the latter normally requires glucose transport. The small remaining increase in Ras2-GTP is consistent with the small remaining increase in glucose 6-phosphate previously observed in the glucose transport deficient strain (10, 11). It is apparently sustained by the very low level of residual glucose transport in this strain, but it is unable to support cAMP signaling. Deletion of GPR1 or GPA2 in the glucose transport-deficient strain also enhanced the basal level of Ras2-GTP in agreement with the previous observation that the GPCR system negatively affects Ras2 GTP loading. There was no further glucose-induced increase in the Ras2-GTP level, which can be explained by the absence of glucose transport and sufficient glucose phosphorylation.



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 7.
Kinetics of glucose-induced Ras2-GTP loading in strains lacking glucose transporters. GTP-content of Ras2 after the addition of 100 mM glucose to wild type MC996A ({square}), hxt1–7{Delta} gal2{Delta} ({diamondsuit}), hxt1–7{Delta} gal2{Delta} gpr1{Delta} (), and hxt1–7{Delta} gal2{Delta} gpa2{Delta} ({blacktriangleup}) strains. The kinetics of Ras2-GTP in MC996A is different from that usually observed in other wild type strains. Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 
Ras2 Is a Possible Target of the Feedback-inhibition Mechanism—cAMP accumulation in yeast is under strong feedback inhibition by protein kinase A (17, 18). The only target conclusively identified so far is the low-affinity cAMP phosphodiesterase Pde1 (19). To evaluate whether the feedback-inhibition mechanism on cAMP accumulation by PKA acts by changing the Ras2 protein activation state, we measured the Ras2-GTP/total Ras2 ratio in a strain with reduced feedback inhibition (tpk1w1 tpk2{Delta} tpk3{Delta}). The initial Ras2-GTP level was about 3 times higher compared with that in wild type cells, and the Ras2-GTP level further increased after the addition of glucose (Fig. 8). These results indicate that PKA down-regulates the Ras2 GTP-loading state. Deletion of GPA2 gene did not prevent the increase in the basal level of Ras2-GTP or the glucose-induced increase. This confirms that the glucose-induced increase in Ras2-GTP does not require the GPCR system and is apparently only triggered by the glucose phosphorylation-dependent system.



View larger version (14K):
[in this window]
[in a new window]
  		FIG. 8.
Ras2 activation is overstimulated in strains with reduced feedback inhibition. GTP content of Ras2 after the addition of 100 mM glucose to cells of wild type SP1 ({blacksquare}), SP1 tpk1w1 ({blacktriangleup}), and SP1 tpk1w1 gpa2{Delta} ({circ}) strains. Treatment of cells and determination of the Ras2-GTP content were as described in the legend for Fig. 2.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Involvement of Ras in Glucose-induced cAMP Signaling— The first evidence for involvement of the Ras proteins in cAMP signaling was provided by Broek et al. (20), Toda et al. (21), and Mbonyi et al. (22). Subsequent work also supported a requirement of CDC25 in glucose-induced cAMP signaling (23–26). The involvement of Ras in glucose-induced cAMP signaling was further supported by the inability of a Ras mutant allele that lacked lipid modification and therefore plasma membrane attachment to mediate glucose-induced cAMP signaling although the allele could support a basal cAMP level high enough for growth (27, 28). After Colombo et al. (5) showed that only intracellular acidification and not glucose caused an increase in the GTP content on the Ras proteins, attention re-focused on the Gpa2 protein and its G-protein-coupled receptor Gpr1 as a glucose-sensing module required for activation of cAMP synthesis. The latter, however, did not explain the many previous results supporting a role for the Cdc25-Ras module in glucose-induced cAMP signaling. Moreover, Rudoni et al. (6) have recently been able to detect a glucose-induced increase in the Ras2-GTP content with a more sensitive assay. Our present results reconcile the discrepancies between the previous findings. Using the more sensitive assay for the Ras2 GTP detection we show that glucose addition rapidly enhances Ras2-GTP. We confirm that intracellular acidification enhances the GTP loading on Ras. Moreover we show that overexpression of Ras2 delays the increase caused by intracellular acidification and abolishes the increase triggered by glucose. This explains the inability of Colombo et al. (5) to detect an increase in the GTP/GDP ratio on Ras2 because they necessarily had to use Ras2 overexpression strains to be able to measure the GTP and GDP load on Ras2 because of the lower sensitivity of the method. The strong Ras2 overexpression (up to 15-fold) could impair the glucose responding mechanism in different ways. Whereas the ratio Ras2-GTP/total Ras2 was comparable with that found in the wild type strain, the absolute amount of Ras2-GTP was very high, with a 10–15-fold increase; therefore the pathway is overstimulated and no additional increase of Ras2-GTP can be induced by glucose, or the high amount of Ras2-GTP can inhibit any additional Ras2-GTP increase. Alternatively the overexpression of Ras2 dilutes the amount available for stimulation and therefore reduces the glucose-induced Ras2-GTP increase to below the detection limit. Another explanation is that overexpression of Ras2 causes mislocalization of the protein with inaccessibility to the activation mechanism as a result. Immunofluorescence staining, however, showed that in the strain overexpressing Ras2 the protein was localized mainly at the plasma membrane (results not shown). In conclusion, the glucose-induced stimulation of cAMP synthesis is apparently mediated by the two G-proteins, Ras2 and Gpa2, raising the question as to the mechanisms involved in glucose activation of Ras.

Mechanism of Glucose Activation of Ras—Yeast Ras activation is controlled by the guanine nucleotide exchange proteins Cdc25 and Sdc25 of which the former plays a major role (29). We show that deletion of CDC25 severely delays the glucose-induced increase in Ras2-GTP consistent with a requirement of Cdc25. The slow residual increase might be mediated by Sdc25. This result opens the possibility that Cdc25 would act as a signal mediator for glucose-induced activation of Ras. On the other hand, also in case the glucose signal would arrive on the Ira proteins, causing their inhibition, a requirement for Cdc25 as GDP/GTP exchange stimulator could be expected. Deletion of the IRA genes, and in particular the IRA2 gene, caused a conspicuous increase in the basal level of Ras2-GTP. This is consistent with previous results obtained by Tanaka et al. (14) revealing a role for the Ira proteins as Ras-GTPase activating proteins. As opposed to the results of Tanaka et al. (14), however, which were obtained with strains overexpressing Ras2, our results were obtained with strains displaying regular Ras2 expression. More importantly, the ira2{Delta} and ira1{Delta} ira2{Delta} strains did not show a further glucose-induced increase in Ras2-GTP. The level of Ras2-GTP in these strains was higher in comparison to the maximal levels observed in wild type strains, but because Ras2-GTP was about 20% of the total Ras2 content one would expect a further increase to be possible. The results indicate that the glucose-induced rise in Ras2-GTP might be mediated by inhibition of the Ira proteins. As mentioned previously, in this scenario deletion of CDC25 would also be expected to cause a delay of the glucose-induced increase in Ras2-GTP because Cdc25 is required to load Ras with GTP. On the other hand, if Cdc25 would be the mediator of glucose signaling, one would expect a further glucose-induced increase in the ira2{Delta} and ira1{Delta} ira2{Delta} strains. The inability of Colombo et al. (5) to detect a glucose-induced increase in GTP on Ras refocused the attention on Gpa2 and led to the discovery of the Gpr1-Gpa2-Rgs2 GPCR module as the glucose-sensing system for activation of the cAMP pathway (2, 3, 5, 11, 30–32). Our results now show that this module is not required for glucose activation of Ras2. Deletion of GPR1 or GPA2 did not prevent the glucose-induced increase in Ras2-GTP. Unexpectedly, deletion of GPR1 and especially of GPA2 also enhanced the levels of Ras2-GTP. This points to a competition between the two G-protein systems. One possibility is that the two G-proteins compete for interaction with adenylate cyclase. Inactivation of the Gpr1-Gpa2 module might facilitate interaction of Ras with adenylate cyclase, and if this interaction would decrease the accessibility of Ras to the Ira proteins a more persistent Ras2-GTP load could be the final result.

Despite the discovery of the Gpr1-Gpa2 glucose-sensing GPCR module, it has been firmly established that glucose activation by this module is also strictly dependent on glucose phosphorylation (10, 11). It is awkward that a ligand of a GPCR system has to be transported and modified in metabolism before the same ligand can activate the effector system through its GPCR system. It is unclear how glucose phosphorylation primes adenylate cyclase for activation by the GPCR system. Our present results might lead to an answer to this question. The glucose-induced increase in Ras2-GTP was absent in a glucose phosphorylation-deficient strain (hxk1{Delta} hxk2{Delta} glk1{Delta}). The glucokinase Glk1 was sufficient to sustain an increase in Ras2-GTP although it was somewhat reduced compared with that in the wild type strain. These results indicate that glucose phosphorylation might lead to a higher activity of Ras to prime adenylate cyclase for activation by the GPCR system. Unexpectedly, deletion of GPR1 or GPA2 caused an increase in the initial level of Ras2-GTP. This might indicate that the inactive GPCR may act as inhibitors of Ras2 GTP loading. Activation by the GPCR system and by the glucose phosphorylation-dependent system can be differentiated to some extent by their different glucose concentration requirement (10). Because the glucose-induced effects are measured in derepressed cells, the Km of glucose transport is low (about 1–2 mM), and the addition of such a low level of glucose results in active glucose transport and phosphorylation. The GPCR system, however, is only activated by much higher concentrations in the order of 25–100 mM. Hence, sequential addition of a low and a high glucose concentration can be used to differentiate between the contribution of the two systems in glucose-induced cAMP signaling. Addition of 5 mM glucose did not trigger an increase in Ras2-GTP in a wild type strain as opposed to the subsequent addition of 100 mM glucose. However, in the gpr1{Delta} and gpa2{Delta} strain there was also an increase with 5 mM glucose. Although the absence of an increase in Ras2 GTP after the addition of 5 mM glucose in the wild type strain is puzzling, the presence of an increase in the gpr1{Delta} and gpa2{Delta} strains with 5 mM glucose indicates that low glucose concentrations are triggering the activation mechanism of Ras2. Possibly, the GTP/GDP turnover of Ras2 in the wild type strain is so high that no net increase in the GTP activation state can be measured. Hence, low glucose concentrations might still activate adenylate cyclase through activation of Ras2, but detection of the latter would require a stabilization of GTP-loaded Ras2 as apparently happens in the gpr1{Delta} and gpa2{Delta} strains. Therefore, the increase in Ras2-GTP in the gpr1{Delta} and gpa2{Delta} strains with a low glucose concentration supports the idea that glucose phosphorylation acts through the Ras proteins. Obviously, higher external glucose concentrations will lead to faster transport and faster intracellular glucose phosphorylation, consistent with the further increase in Ras2-GTP upon the addition of 100 mM glucose. In conclusion, the most appealing hypothesis concerning the mechanism by which glucose increases the GTP-loading on the Ras2 protein is that the glucose phosphorylation-dependent mechanism causes inhibition of the Ira proteins. This switches the equilibrium between Cdc25 stimulated exchange of GDP for GTP and GTP hydrolysis by the Ira-stimulated GTPase activity of the Ras2 protein to GTP-loading resulting in a rapid increase in Ras2-GTP. This hypothesis is also in agreement with the observation that deletion of IRA2 in a triple glucose kinases deleted strain produced a high level of Ras2-GTP. Although further work is required to substantiate this hypothesis it provides an elegant explanation for the dual requirement in glucose activation of cAMP synthesis. It also reconciles the former results indicating involvement of the Cdc25-Ras module and the more recent results on glucose sensing by the GPCR module. Possibly, the double G-protein control of adenylate cyclase serves to integrate sensing of extracellular glucose with the sensing of intracellular glucose.

Feedback Inhibition of Adenylate Cyclase—Colombo et al. (5) were unable to detect an increase in the GTP content on Ras in a strain with reduced feedback inhibition. This might be because of the same technical problem of the assay as discussed previously because with the current assay a significant increase in the basal level of Ras2-GTP was detected in a PKA-attenuated strain. Importantly, also the glucose-induced increase in Ras2-GTP was prominently present making it unlikely that the latter is caused by reduction of the feedback inhibition. Deletion of GPA2 did not affect the basal level of Ras2-GTP nor the glucose-induced increase indicating that the feedback inhibition proceeds independently from the GPCR module. Although the Ras proteins have been suggested as a target of the feedback inhibition the proposed mechanism, phosphorylation-induced reduction of adenylate cyclase interaction, did not involve changes in the GTP/GDP content of Ras (33). Cdc25 has also been proposed as a target of the feedback-inhibition mechanism. It is phosphorylated in response to glucose, and this reduces its accessibility to Ras (34). A mutation in the Cdc25 C terminus was identified that reduces feedback inhibition after glucose-induced stimulation of cAMP synthesis (25). The Ira proteins have also been suggested as possible targets of the feedback-inhibition mechanism (35), but this has not been substantiated further. Although the Cdc25 and Ira proteins are the most likely candidates for the feedback-inhibition mechanism to explain the increased Ras2-GTP content in a PKA-attenuated strain, it cannot be excluded that modification of adenylate cyclase would affect the Ras2-GTP loading state. Actually, deletion of GPA2 or GPR1 also enhanced the Ras2-GTP level although not as pronounced as in the PKA-attenuated strain. Because deletion of GPA2 in the PKA-attenuated strain did not further enhance the basal Ras2-GTP content its effect on the Ras2-GTP level might be related to the feedback-inhibition mechanism.


   FOOTNOTES
 
* This work was supported by grant Fondo Agevolazioni alla Ricera, ex 60% (FAR) (to E. M.) and by grants from the Fund for Scientific Research-Flanders (to J. W. and J. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

|| To whom correspondence should be addressed. Tel.: 39-02-64483533; Fax: 39-02-64483565; E-mail: Enzo.Martegani{at}unimib.it.

1 The abbreviations used are: PKA, protein kinase A; RBD, Ras-binding domain; MES, 4-morpholinoethanesulfonic acid; GST, glutathione S-transferase; GPCR, G-protein-coupled receptor. Back


   ACKNOWLEDGMENTS
 
We thank A. Wittinghofer for providing the expression vector for the production of GST-RBD and Katrien Pardons (Katholieke Universiteit Leuven) for providing strain glk1::LEU2 hxk1::HIS3 hxk2::LEU2 ira2::URA3.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Nakafuku, M., Obara, T., Kaibuchi, K., Miyajima, I., Miyajima, A., Itoh, H., Nakamura, S., Arai, K., Matsumoto, K., and Kaziro, Y. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1374–1378[Abstract/Free Full Text]
  2. Kraakman, L., Lemaire, K., Ma, P., Teunissen, A. W., Donaton, M. C., Van Dijck, P., Winderickx, J., de Winde, J. H., and Thevelein, J. M. (1999) Mol. Microbiol. 32, 1002–1012A. W.[CrossRef][Medline] [Order article via Infotrieve]
  3. Xue, Y., Montserrat, B., and Hirsch, J. P. (1998) EMBO J. 17, 1996–2007[CrossRef][Medline] [Order article via Infotrieve]
  4. Yun, C., W., Tamaki, H., Nakayama, R., Yamamoto, K., and Kumagai, H. (1997) Biochem. Biophys. Res. Commun. 240, 287–292[CrossRef][Medline] [Order article via Infotrieve]
  5. Colombo, S., Ma, P., Cauwenberg, L., Winderickx, J., Crauwels, M., Teunissen, A., Nauwelaers, D., de Winde, J. H., Gorwa, M. F., Colavizza, D., and Thevelein, J. M. (1998) EMBO J. 17, 3326–3341[CrossRef][Medline] [Order article via Infotrieve]
  6. Rudoni, S., Colombo, S., Coccetti, P., and Martegani, E. (2001) Biochim. Biophys. Acta 1538, 181–189[Medline] [Order article via Infotrieve]
  7. Gibbs, J., B., Schaber, M. D., Marshall, M. S., Scolnick, E. M., and Sigal, I. S. (1987) J. Biol. Chem. 262, 10426–10429[Abstract/Free Full Text]
  8. Taylor, S., and Shalloway, D. (1996) Curr. Biol. 6, 1621–1627[CrossRef][Medline] [Order article via Infotrieve]
  9. Beullens, M., Mbonyi, K., Geerts, L., Gladines, D., Detremerie, K., Jans, A. W. H., and Thevelein, J. M. (1988) Eur. J. Biochem. 172, 227–231[Medline] [Order article via Infotrieve]
  10. Rolland, F., de Winde, J. H., Lemaire, K., Boles, E., Thevelein, J. M., and Winderickx, J. (2000) Mol. Microbiol. 38, 348–358[CrossRef][Medline] [Order article via Infotrieve]
  11. Rolland, F., Wanke, V., Cauwenberg, L., Ma, P., Boles, E., Vanoni, M., de Winde, J. H., Thevelein, J. M., and Winderickx, J. (2001) FEMS Yeast Res. 1403, 1–13
  12. Robinson, L. A., Gibbs, J. B., Marshall, M. S., Sigal, I. S., and Tatchell, K. (1987) Science 235, 1218–1221[Abstract/Free Full Text]
  13. Jacquet, E., Parrini, M. C., Bernardi, E., Martegani, E., and Parmeggiani, A. (1994) Biochem. Biophys. Res. Commun. 199, 497–503[CrossRef][Medline] [Order article via Infotrieve]
  14. Tanaka, K., Nakafuku, M., Satoh, T., Marshall, M. S., Gibbs, J. B., Matsumoto, K., Kaziro, Y., and Toh-e, A. (1990) Cell 60, 803–807[CrossRef][Medline] [Order article via Infotrieve]
  15. Lobo, Z., and Maitra, P. K. (1977) Genetics 86, 727–744[Abstract/Free Full Text]
  16. Maitra, P. K., and Lobo, Z. (1983) Genetics 105, 501–515[Abstract/Free Full Text]
  17. Nikawa, J., Cameron, S., Toda, T., Ferguson, K. W., and Wigler, M. (1987) Genes Dev. 1, 931–937[Abstract/Free Full Text]
  18. Mbonyi, K., Van Aelst, L., Argüelles, J. C., Jans A. W. H., and Thevelein, J. M. (1990) Mol. Cell. Biol. 10, 4518–4523[Abstract/Free Full Text]
  19. Ma, P., Wera, S., Van Dijck, P., and Thevelein, J. M. (1999) Mol. Biol. Cell 10, 91–104[Abstract/Free Full Text]
  20. Broek, D., Samily, N., Fasano, O., Fujiyama, A., Tamanoi, F., Northup, J., and Wigler, M. (1985) Cell 41, 763–769[CrossRef][Medline] [Order article via Infotrieve]
  21. Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J., Matsumoto, K., and Wigler, M. (1985) Cell 40, 27–36[CrossRef][Medline] [Order article via Infotrieve]
  22. Mbonyi, K., Beullens, M., Detremerie, K., Geerts, L., and Thevelein, J. M. (1988) Mol. Cell. Biol. 8, 3051–3057[Abstract/Free Full Text]
  23. Munder, T., and Küntzel, H., (1989) FEBS Lett. 242, 341–354[CrossRef][Medline] [Order article via Infotrieve]
  24. Van Aelst, L., Boy-Marcotte, E., Camonis, J. H., Thevelein, J. M., and Jacquet, M. (1990) Eur. J. Biochem. 193, 675–680[Medline] [Order article via Infotrieve]
  25. Schomerus, C., Munder, T., and Küntzel, H., (1990) Mol. Gen. Genet. 223, 426–432[Medline] [Order article via Infotrieve]
  26. Van Aelst, L., Jans, A. W. H., and Thevelein, J. M. (1991) J. Gen. Microbiol. 137, 341–349[Abstract/Free Full Text]
  27. Bhattacharya, S., Chen, L., Broach, J. R., and Powers, S. (1995) (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2984–2988[Abstract/Free Full Text]
  28. Jiang, Y., Davis, C., and Broach, J. R. (1998) EMBO J. 17, 6942–6951[CrossRef][Medline] [Order article via Infotrieve]
  29. Boy-Marcotte, E., Ikonomi, P., and Jacquet, M. (1996) Mol. Biol. Cell 7, 529–539[Abstract]
  30. Thevelein, J. M., and de Winde, J. H. (1999) Mol. Microbiol. 33, 904–918[CrossRef][Medline] [Order article via Infotrieve]
  31. Lorenz, M. C., Pan, X., Harashima, T., Cardenas, M. E., Xue, Y., Hirsch, J. P., and Heitman, J. (2000) Genetics 154, 609–622M. C.[Abstract/Free Full Text]
  32. Versele, M., Lemaire K., and Thevelein, J. M. (2001) EMBO Rep. 2, 574–579[CrossRef][Medline] [Order article via Infotrieve]
  33. Resnick, R. J., and Racker, E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2474–2478[Abstract/Free Full Text]
  34. Gross, E., Goldberg, D., and Levitzki, A. (1992) Nature 360, 762–765[CrossRef][Medline] [Order article via Infotrieve]
  35. Tanaka, K., Matsumoto, K., and Toh-e, A. (1989) Mol. Cell. Biol. 9, 757–768[Abstract/Free Full Text]
  36. Thomas, B. J., and Rothstein, R. (1989) Cell 56, 619–630[CrossRef][Medline] [Order article via Infotrieve]
  37. de Winde, J. H., Crauwels, M., Hohmann, S., Thevelein, J. M., and Winderickx, J. (1996) Eur. J. Biochem. 241, 633–643J. H.[Medline] [Order article via Infotrieve]
  38. Reifenberger, E., Freidel, K., and Ciriacy, M. (1995) Mol. Microbiol. 16, 157–167[Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
J. E. Leadsham, K. Miller, K. R. Ayscough, S. Colombo, E. Martegani, P. Sudbery, and C. W. Gourlay
Whi2p links nutritional sensing to actin-dependent Ras-cAMP-PKA regulation and apoptosis in yeast
J. Cell Sci., March 1, 2009; 122(5): 706 - 715.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Bond and M. Forgac
The Ras/cAMP/Protein Kinase A Pathway Regulates Glucose-dependent Assembly of the Vacuolar (H+)-ATPase in Yeast
J. Biol. Chem., December 26, 2008; 283(52): 36513 - 36521.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
H. M. Kang, C. Ye, and E. Eskin
Accurate Discovery of Expression Quantitative Trait Loci Under Confounding From Spurious and Genuine Regulatory Hotspots
Genetics, December 1, 2008; 180(4): 1909 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Diaz-Ruiz, N. Averet, D. Araiza, B. Pinson, S. Uribe-Carvajal, A. Devin, and M. Rigoulet
Mitochondrial Oxidative Phosphorylation Is Regulated by Fructose 1,6-Bisphosphate: A POSSIBLE ROLE IN CRABTREE EFFECT INDUCTION?
J. Biol. Chem., October 3, 2008; 283(40): 26948 - 26955.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. E. Zeller, S. C. Parnell, and H. G. Dohlman
The RACK1 Ortholog Asc1 Functions as a G-protein beta Subunit Coupled to Glucose Responsiveness in Yeast
J. Biol. Chem., August 24, 2007; 282(34): 25168 - 25176.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. W. Gourlay and K. R. Ayscough
Actin-Induced Hyperactivation of the Ras Signaling Pathway Leads to Apoptosis in Saccharomyces cerevisiae.
Mol. Cell. Biol., September 1, 2006; 26(17): 6487 - 6501.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
R. S. Kao, E. Morreale, L. Wang, F. D. Ivey, and C. S. Hoffman
Schizosaccharomyces pombe Git1 Is a C2-Domain Protein Required for Glucose Activation of Adenylate Cyclase
Genetics, May 1, 2006; 173(1): 49 - 61.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
F. Belotti, R. Tisi, and E. Martegani
The N-terminal region of the Saccharomyces cerevisiae RasGEF Cdc25 is required for nutrient-dependent cell-size regulation.
Microbiology, April 1, 2006; 152(Pt 4): 1231 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
G. M. Santangelo
Glucose Signaling in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev., March 1, 2006; 70(1): 253 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. M. Maidan, L. De Rop, J. Serneels, S. Exler, S. Rupp, H. Tournu, J. M. Thevelein, and P. Van Dijck
The G Protein-coupled Receptor Gpr1 and the G{alpha} Protein Gpa2 Act through the cAMP-Protein Kinase A Pathway to Induce Morphogenesis in Candida albicans
Mol. Biol. Cell, April 1, 2005; 16(4): 1971 - 1986.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
C. S. Hoffman
Except in Every Detail: Comparing and Contrasting G-Protein Signaling in Saccharomyces cerevisiae and Schizosaccharomyces pombe
Eukaryot. Cell, March 1, 2005; 4(3): 495 - 503.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/45/46715    most recent
M405136200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colombo, S.
Right arrow Articles by Martegani, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colombo, S.
Right arrow Articles by Martegani, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement